Integrative Mendelian Randomization approaches for therapeutic target prioritisation in immune-mediated diseases
Maria K. Sobczyk, Tom R. Gaunt
This study uses Mendelian Randomization to prioritize drug targets for immune-mediated diseases by analyzing immune cell abundance and protein QTLs, identifying potential repurposing opportunities.